Co-Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Co-Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011340
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit. Its products finds application in window period detection in blood screening, viral load for monitoring the success of treatment, and infant diagnosis for detecting disease in infants, among others. The company’s technologies comprise Co-Dx, a suite of mathematically-engineered DNA-based polymerase chain reaction diagnostics products, and Adaptivex which helps primers address the challenge of unexpected mutations. Its technology is designed for new generation mobile point-of-care diagnostic devices, and commercially available devices. Co-Diagnostics is headquartered in Sandy, Utah, the US.

Co-Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Co-Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Co-Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Co-Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Co-Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Co-Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Co-Diagnostics Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Co-Diagnostics To Acquire Additional PCR Primer Tech From DNA Logix 10
Co-Diagnostics Completes Acquisition Of Genetic Analysis Technologies From DNA Logix 11
Venture Financing 12
Co-Diagnostics Raises USD0.8 Million in Venture Financing 12
Partnerships 13
Biosearch Enters into Licensing Agreement with Co-Diagnostics 13
Lab21 Enters Into Licensing Agreement With Cooperative Diagnostics 14
Co-Diagnostics Forms Joint Venture With DNA Logix 15
Equity Offering 16
Co-Diagnostics to Raise up to USD8.7 Million in IPO 16
Asset Transactions 17
Co-Diagnostics To Acquire Additional PCR Primer Tech From DNA Logix 17
Co-Diagnostics Completes Acquisition Of Genetic Analysis Technologies From DNA Logix 18
Co-Diagnostics Inc – Key Competitors 19
Co-Diagnostics Inc – Key Employees 20
Co-Diagnostics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Recent Developments 22
Strategy And Business Planning 22
Nov 07, 2017: Co-Diagnostics Manufacturing Joint Venture Breaks Ground in India 22
Financial Announcements 23
Nov 15, 2017: Co-Diagnostics Reports Q3 Financial Results and Updates Corporate Developments 23
Legal and Regulatory 24
Nov 02, 2017: Co-Diagnostics Granted ISO 13485:2016 Certification 24
Other Significant Developments 25
Dec 19, 2017: Co-Diagnostics Enters Into Lease for New, Upgraded Laboratory Facility 25
Sep 05, 2017: Co-Diagnostics to Sign Purchase Agreement with MEDCIS Pathlabs 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Co-Diagnostics Inc, Medical Equipment, Key Facts 2
Co-Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Co-Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Co-Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Co-Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Co-Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
Co-Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Co-Diagnostics To Acquire Additional PCR Primer Tech From DNA Logix 10
Co-Diagnostics Completes Acquisition Of Genetic Analysis Technologies From DNA Logix 11
Co-Diagnostics Raises USD0.8 Million in Venture Financing 12
Biosearch Enters into Licensing Agreement with Co-Diagnostics 13
Lab21 Enters Into Licensing Agreement With Cooperative Diagnostics 14
Co-Diagnostics Forms Joint Venture With DNA Logix 15
Co-Diagnostics to Raise up to USD8.7 Million in IPO 16
Co-Diagnostics To Acquire Additional PCR Primer Tech From DNA Logix 17
Co-Diagnostics Completes Acquisition Of Genetic Analysis Technologies From DNA Logix 18
Co-Diagnostics Inc, Key Competitors 19
Co-Diagnostics Inc, Key Employees 20
Co-Diagnostics Inc, Subsidiaries 21
Co-Diagnostics Inc, Joint Venture 21

★海外企業調査レポート[Co-Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SRI International:医療機器:M&Aディール及び事業提携情報
    Summary SRI International (SRI) is a non-profit organization that provides commercial research and development programs. The organization’s services include research and development, innovation consulting, technology solutions, bioscience contract research, specialized facilities and services. It pe …
  • Arena Energy LP:石油・ガス:M&Aディール及び事業提携情報
    Summary Arena Energy Lp (Arena) operates as an oil and gas exploration company. It is engaged in developing and exploring of oil and gas in Gulf of Mexico. It identifies and develops investment opportunities in the Gulf of Mexico Shelf. It is also involved in drilling and off-shore activities. The c …
  • STATS ChipPAC Pte Ltd:企業の戦略的SWOT分析
    STATS ChipPAC Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Medicago Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a clinical-stage biotechnology company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. I …
  • Asian Citrus Holdings Ltd. (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd. (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • NII Holdings, Inc.:戦略・SWOT・企業財務分析
    NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Naturgy Energy Group SA. (NTGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Naturgy Energy Group SA (Naturgy) formerly know as Gas Natural Fenosa, is an integrated gas and electric utility that carries out the exploration, development, liquefaction, regasification, transportation, storage, distribution and commercialization of natural gas. It also undertakes the gen …
  • Travelport Limited (TVPT):企業の財務・戦略的SWOT分析
    Travelport Limited (TVPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Extreme Networks, Inc. (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks, Inc. (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Applied Industrial Technologies Inc (AIT):企業の財務・戦略的SWOT分析
    Applied Industrial Technologies Inc (AIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Choice Hotels International Inc:戦略・SWOT・企業財務分析
    Choice Hotels International Inc - Strategy, SWOT and Corporate Finance Report Summary Choice Hotels International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Daybreak Oil and Gas Inc (DBRM):企業の財務・戦略的SWOT分析
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • AGILeBiotics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary AGILeBiotics BV (AGILeBiotics) is a pharmaceutical company that focus on the discovery and development of new antibiotics to treat multi-drug resistant infections. The company’s patented synthetic method technology OxaSelect transforms the currently available antibiotics, which became less e …
  • Johnston Press plc:企業の戦略的SWOT分析
    Johnston Press plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • United Utilities Group Plc (UU):企業の財務・戦略的SWOT分析
    United Utilities Group Plc (UU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Marriott Vacations Worldwide Corporation:企業の戦略・SWOT・財務情報
    Marriott Vacations Worldwide Corporation - Strategy, SWOT and Corporate Finance Report Summary Marriott Vacations Worldwide Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Versum Materials, Inc. (VSM):企業の財務・戦略的SWOT分析
    Versum Materials, Inc. (VSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Anteo Diagnostics Ltd (ADO):医療機器:M&Aディール及び事業提携情報
    Summary Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinica …
  • Foundation Medicine Inc (FMI)-医療機器分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …
  • Maruho Co Ltd:企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆